Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis.

MLA

Bignotti, Eliana, et al. “Secretoglobin Expression in Ovarian Carcinoma: Lipophilin B Gene Upregulation as an Independent Marker of Better Prognosis.” Journal of Translational Medicine, vol. 11, no. 1, Aug. 2013, pp. 1–11. EBSCOhost, https://doi.org/10.1186/1479-5876-11-162.

APA

Bignotti, E., Tassi, R. A., Calza, S., Ravaggi, A., Rossi, E., Donzelli, C., Todeschini, P., Romani, C., Bandiera, E., Zanotti, L., Carnazza, M., Quadraro, F., Tognon, G., Sartori, E., Pecorelli, S., Roque, D. M., & Santin, A. D. (2013). Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. Journal of Translational Medicine, 11(1), 1–11. https://doi.org/10.1186/1479-5876-11-162

Chicago

Bignotti, Eliana, Renata A. Tassi, Stefano Calza, Antonella Ravaggi, Elisa Rossi, Carla Donzelli, Paola Todeschini, et al. 2013. “Secretoglobin Expression in Ovarian Carcinoma: Lipophilin B Gene Upregulation as an Independent Marker of Better Prognosis.” Journal of Translational Medicine 11 (1): 1–11. doi:10.1186/1479-5876-11-162.